Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Trabectedin

EU orphan designation number: EU/3/03/171   
Active ingredient: Trabectedin
Indication: Treatment of ovarian cancer
Sponsor: Pharma Mar S.A.
Avda de los Reyes 1, Polígono Industrial La Mina, E-28770 Colmenar Viejo, Madrid, España
EU Centralised marketing authorisation: A centralised EU marketing authorisation has been obtained under the name Yondelis on 17/09/2007 with the number EU/1/07/417

   Public summary of scientific opinion     EPAR

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/10/2003 Centralised Orphan - Designation EMEA/OD/044/03 (2003)3935 of 17/10/2003